• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.26% Nasdaq Up1.58%

    Merrimack Pharmaceuticals, Inc. (MACK)

    -NasdaqGM
    10.18 Up 0.10(0.94%) 3:24PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 28,002   27,815   13,034   7,823  
    Cost of Revenue -   -   -   -  
    Gross Profit 28,002   27,815   13,034   7,823  
    Operating Expenses
    Research Development43,632  33,795  30,324  30,055  
    Selling General and Administrative8,095  7,921  6,224  6,010  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (23,725) (13,901) (23,514) (28,242)
    Income from Continuing Operations
    Total Other Income/Expenses Net272  181  271  373  
    Earnings Before Interest And Taxes(23,453)(13,720)(23,243)(27,869)
    Interest Expense4,585  4,570  4,511  4,479  
    Income Before Tax(28,038)(18,290)(27,754)(32,348)
    Income Tax Expense -   -   -   -  
    Minority Interest137  181  169  (711)
    Net Income From Continuing Ops(27,901)(18,109)(27,585)(33,059)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (27,901) (18,109) (27,585) (33,059)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (27,901) (18,109) (27,585) (33,059)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.